133 related articles for article (PubMed ID: 7599065)
1. Differential effects of depleting agents on cytoplasmic and nuclear non-protein sulphydryls: a fluorescence image cytometry study.
Thomas M; Nicklee T; Hedley DW
Br J Cancer; 1995 Jul; 72(1):45-50. PubMed ID: 7599065
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of methods for measuring cellular glutathione content using flow cytometry.
Hedley DW; Chow S
Cytometry; 1994 Apr; 15(4):349-58. PubMed ID: 8026225
[TBL] [Abstract][Full Text] [Related]
3. The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation.
Hamilos DL; Wedner HJ
J Immunol; 1985 Oct; 135(4):2740-7. PubMed ID: 4031498
[TBL] [Abstract][Full Text] [Related]
4. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery.
Bertsche U; Schorn H
Radiat Res; 1986 Mar; 105(3):351-69. PubMed ID: 3754339
[TBL] [Abstract][Full Text] [Related]
5. Relations between non-protein sulfydryl levels in the nucleus and cytoplasm, tumor oxygenation, and clinical outcome of patients with uterine cervical carcinoma.
Hedley DW; Nicklee T; Moreno-Merlo F; Pintilie M; Fyles A; Milosevic M; Hill RP
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):137-44. PubMed ID: 15629604
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of cellular glutathione by flow cytometry utilizing monochlorobimane: some applications to radiation and drug resistance in vitro and in vivo.
Rice GC; Bump EA; Shrieve DC; Lee W; Kovacs M
Cancer Res; 1986 Dec; 46(12 Pt 1):6105-10. PubMed ID: 3779630
[TBL] [Abstract][Full Text] [Related]
7. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
Kramer RA; Greene K; Ahmad S; Vistica DT
Cancer Res; 1987 Mar; 47(6):1593-7. PubMed ID: 3815359
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of nuclear compartmentalization of glutathione in hepatocytes.
Bellomo G; Vairetti M; Stivala L; Mirabelli F; Richelmi P; Orrenius S
Proc Natl Acad Sci U S A; 1992 May; 89(10):4412-6. PubMed ID: 1584774
[TBL] [Abstract][Full Text] [Related]
9. Cellular glutathione depletion by diethyl maleate or buthionine sulfoximine: no effect of glutathione depletion on the oxygen enhancement ratio.
Mitchell JB; Russo A; Biaglow JE; McPherson S
Radiat Res; 1983 Nov; 96(2):422-8. PubMed ID: 6647769
[TBL] [Abstract][Full Text] [Related]
10. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.
Meijer C; Mulder NH; Hospers GA; Uges DR; de Vries EG
Br J Cancer; 1990 Jul; 62(1):72-7. PubMed ID: 2390486
[TBL] [Abstract][Full Text] [Related]
11. The role of thiols in cellular response to radiation and drugs.
Biaglow JE; Varnes ME; Clark EP; Epp ER
Radiat Res; 1983 Sep; 95(3):437-55. PubMed ID: 6684310
[TBL] [Abstract][Full Text] [Related]
12. Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro.
Shrieve DC; Denekamp J; Minchinton AI
Radiat Res; 1985 Jun; 102(3):283-94. PubMed ID: 4070545
[TBL] [Abstract][Full Text] [Related]
13. Buthionine sulfoximine-induced cytostasis does not correlate with glutathione depletion.
Kang YJ; Enger MD
Am J Physiol; 1992 Jan; 262(1 Pt 1):C122-7. PubMed ID: 1733228
[TBL] [Abstract][Full Text] [Related]
14. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
Ali-Osman F; Antoun G; Wang H; Rajagopal S; Gagucas E
Mol Pharmacol; 1996 Jun; 49(6):1012-20. PubMed ID: 8649339
[TBL] [Abstract][Full Text] [Related]
15. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
Liebmann JE; Hahn SM; Cook JA; Lipschultz C; Mitchell JB; Kaufman DC
Cancer Res; 1993 May; 53(9):2066-70. PubMed ID: 8097674
[TBL] [Abstract][Full Text] [Related]
16. Depletion of tumour versus normal tissue glutathione by buthionine sulfoximine.
Lee FY; Allalunis-Turner MJ; Siemann DW
Br J Cancer; 1987 Jul; 56(1):33-8. PubMed ID: 3620316
[TBL] [Abstract][Full Text] [Related]
17. Depletion of tumour glutathione in vivo by buthionine sulphoximine: modulation by the rate of cellular proliferation and inhibition of cancer growth.
Terradez P; Asensi M; Lasso de la Vega MC; Puertes IR; Viña J; Estrela JM
Biochem J; 1993 Jun; 292 ( Pt 2)(Pt 2):477-83. PubMed ID: 8503882
[TBL] [Abstract][Full Text] [Related]
18. Role of glutathione and dependent enzymes in anthracycline-resistant HL60/AR cells.
Lutzky J; Astor MB; Taub RN; Baker MA; Bhalla K; Gervasoni JE; Rosado M; Stewart V; Krishna S; Hindenburg AA
Cancer Res; 1989 Aug; 49(15):4120-5. PubMed ID: 2568167
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine.
Kable EP; Favier D; Parsons PG
Cancer Res; 1989 May; 49(9):2327-31. PubMed ID: 2706620
[TBL] [Abstract][Full Text] [Related]
20. Toxic effects of acute glutathione depletion by buthionine sulfoximine and dimethylfumarate on murine mammary carcinoma cells.
Dethlefsen LA; Lehman CM; Biaglow JE; Peck VM
Radiat Res; 1988 May; 114(2):215-24. PubMed ID: 3375425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
